Cytotheryx
Rochester, United States· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $120M
Overview
A regenerative medicine company creating engineered cell therapies to repair damaged tissues and organs.
Regenerative MedicineOrthopedicsCardiology
Technology Platform
A platform for engineering and manufacturing specific, therapeutically active cell populations for tissue repair and regeneration.
Funding History
2Total raised:$120M
Venture$60M
Debt$60M
Opportunities
Potential to develop curative, one-time treatments for degenerative diseases with massive patient populations.
Risk Factors
Faces significant scientific, regulatory, and manufacturing hurdles inherent to the cell therapy field.
Competitive Landscape
Competes in the evolving regenerative medicine field, facing challenges related to manufacturing, delivery, and proving long-term efficacy.